Abstract
Protein kinase C stands for a family of phospholipid binding/dependent serine/threonine kinases consisting of ten members subdivided into three subgroups, classical PKCs (α, βI, βII, γ), novel PKCs (δ, ε, η, θ), and atypical PKCs (ζ, ι/λ), according to specific cofactor requirements. Tissue distribution and cellular compartmentalization imply differential, isoform-specific functions linked to distinct signaling cascades. Thus, certain stimuli can lead to differential responses depending on PKC isoform expression, localization, and phosphorylation status in particular biological settings. Activated by diverse extracellular signals PKCs modify the activities of cellular proteins including receptors, enzymes, cytoskeletal proteins, and transcription factors, playing a central role in signaling networks. Several isoforms participate in the regulation of proliferation, survival and cell death, but also tissue polarity and differentiation. Consequently abnormalities in PKC expression and function have been identified in several cancers. Specifically, initiation of squamous cell carcinomas and their malignant progression is associated with distinct changes in specific PKCs. Besides novel specific inhibitors (also targeting mRNAs), the generation of transgenic and knockout mice has allowed direct functional analyses of individual PKCs. Herein we focus on the role of PKCs largely in skin physiology and malignancy. Based on findings in patients, cell culture and animal models, parallels and discrepancies to other tissues are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abbas, T., White, D., Hui, L., et al. (2004). Inhibition of human p53 basal transcription by down-regulation of protein kinase Cδ. J. Biol. Chem. 279:9970–9977.
Akkaraju, G.R., and Basu, A. (2000). Overexpression of protein kinase C-eta attenuates caspase activation and tumor necrosis factor-alpha-induced cell death. Biochem. Biophys. Res. Commun. 279:103–107.
Al, Z., and Cohen, C.M. (1993). Phorbol 12-myristate 13-acetate-stimulated phosphorylation of erythrocyte membrane skeletal proteins is blocked by calpain inhibitors: possible role of protein kinase M. Biochem. J. 296:675–683.
Alt, A., Gartsbein, M., Ohba, M., et al. (2004). Differential regulation of α6β4 integrin by PKC isoforms in murine keratinocytes. Biochem. Biophys. Res. Commun. 314:17–23.
Alt, A., Ohba, M., Li, L., et al. (2001). Protein kinase Cδ-mediated phosphorylation of α6β4 is associated with reduced integrin localization to the hemidesmosome and decreased keratinocyte attachment. Cancer Res. 61:4591–4598.
Asakai, R., Akita, Y., Tamura, K., et al. (1995). Protein kinase C-dependent down-regulation of basic fibroblast growth factor (FGF-2) receptor by phorbol ester and epidermal growth factor in porcine granulosa cells. Endocrinology 136:3470–3479.
Aziz, M.H., Manoharan, H.T., and Verma, A.K. (2007). Protein kinase Cε, which sensitizes skin to sun’s UV radiation-induced cutaneous damage and development of squamous cell carcinomas, associates with Stat3. Cancer Res. 67:1385–1394.
Aziz, M.H., Wheeler, D.L., Bhamb, B., et al. (2006). Protein kinase Cδ overexpressing mice are resistant to chemically but not to UV radiation-induced development of squamous cell carcinomas: a possible link to cytokines and cyclooxygenase-2. Cancer Res. 66:713–722.
Baumann, P., Zigrino, P., Mauch, C., et al. (2000). Membrane-type 1 matrix metallo-proteinase-mediated progelatinase-A activation in non-tumorigenic and tumorigenic human keratinocytes. Br. J. Cancer 83:1387–1393.
Beachy, P.A., Karhadkar, S.S., and Berman, D.M. (2004). Tissue repair and stem cell renewal in carcinogenesis. Nature 432:324–331.
Berrier, A.L., Mastrangelo, A.M., Downward, J., et al. (2000). Activated R-ras, Rac1, PI 3-kinase and PKC-epsilon can each restore cell spreading inhibited by isolated integrin beta1 cytoplasmic domains. J. Cell Biol. 151:1549–1560.
Berry, N., and Nishizuka, Y. (1990). Protein kinase C and T cell activation. Eur. J. Biochem. 189:205–214.
Blass, M., Kronfeld, I., Kazimirski, G., et al. (2002). Tyrosine phosphorylation of protein kinase Cδ is essential for its apoptotic effect in response to etoposide. Mol. Cell. Biol. 22:182–195.
Bossi, O., Gartsbein, M., Leitges, M., et al. (2008). UV irradiation increases ROS production via PKCδ signaling in primary murine fibroblasts. J. Cell Biochem. 105:194–207.
Braiman, L., Alt, A., Kuroki, T., et al. (1999a). Protein kinase Cdelta mediates insulin-induced glucose transport in primary cultures of rat skeletal muscle. Mol. Endocrinol. 13:2002–2012.
Braiman, L., Alt, A., Kuroki, T., et al. (2001a). Activation of protein kinase Czeta induces serine phosphorylation of vamp2 in the glut4 compartment and increases glucose transport in skeletal muscle. Mol. Cell. Biol. 21:7852–7861.
Braiman, L., Alt, A., Kuroki, T., et al. (2001b). Insulin induces specific interaction between insulin receptor and protein kinase C delta in primary cultured skeletal muscle. Mol. Endocrinol. 15:565–574.
Braiman, L., Sheffi-Friedman, L., Bak, A., et al. (1999b). Tyrosine phosphorylation of specific protein kinase C isoenzymes participates in insulin stimulation of glucose transport in primary cultures of rat skeletal muscle. Diabetes 48:1922–1929.
Breitkreutz, D., Bohnert, A., Herzmann, E., et al. (1984). Differentiation specific functions in cultured and transplanted mouse keratinocytes: environmental influences on ultrastructure and keratin expression. Differentiation 26:154–169.
Breitkreutz, D., Braiman-Wiksman, L., Daum, N., et al. (2007). Protein kinase C family: on the crossroads of cell signaling in skin and tumor epithelium. J. Cancer Res. Clin. Oncol. 133:793–808.
Breitkreutz, D., Stark, H.J., Plein, P., et al. (1993). Differential modulation of epidermal keratinization in immortalized (HaCaT) and tumorigenic human skin keratinocytes (HaCaT-ras) by retinoic acid and extracellular Ca2+. Differentiation 54:201–217.
Brodie, C., and Blumberg, P.M. (2003). Regulation of cell apoptosis by protein kinase c δ. Apoptosis 8:19–27.
Buchner, K. (2000). The role of protein kinase C in the regulation of cell growth and in signalling to the cell nucleus. J. Cancer Res. Clin. Oncol. 126:1–11.
Cabodi, S., Calautti, E., Talora, C., et al. (2000). A PKC-eta/Fyn-dependent pathway leading to keratinocyte growth arrest and differentiation. Mol. Cell 6:1121–1129.
Cacace, A.M., Ueffing, M., Han, E.K.H., et al. (1998). Overexpression of PKCε in R6 fibroblasts causes increased production of active TGFβ. J. Cell Physiol. 175:314–322.
Cai, H., Smola, U., Wixler, V., et al. (1997). Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of the raf-1 protein kinase. Mol. Cell. Biol. 17:732–741.
Cameron, A.J., Procyk, K.J., Leitges, M., et al. (2008). PKC alpha protein but not kinase activity is critical for glioma proliferation and survival. Int. J. Cancer 123:769–779.
Cardell, M., Landsend, A.S., Eidet, J., et al. (1998). High resolution immunogold analysis reveals distinct subcellular compartmentalization of protein kinase C gamma and delta in rat Purkinje cells. Neuroscience 82:709–725.
Castagna, M., Takai, Y., Kaibuchi, K., et al. (1982). Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J. Biol. Chem. 257:7847–7851.
Cataisson, C., Joseloff, E., Murillas, R., et al. (2003). Activation of cutaneous protein kinase Calpha induces keratinocyte apoptosis and intraepidermal inflammation by independent signaling pathways. J. Immunol. 171:2703–2713.
Chauhan, V.P.S., Chauha, A., Deshmukh, D.S., et al. (1990). Lipid activators of protein kinase C. Life Sci. 47:981–986.
Chen, C.C., and Wu, M.L. (1995). Protein kinase C isoform delta is involved in the stimulation of the Na(+)-H+ exchanger in C6 glioma cells. Mol. Pharmacol. 48:995–1003.
Chen, D., Gould, C., Garza, R., et al. (2007). Amplitude control of protein kinase C by RINCK, a novel E3 ubiqutin ligase. J. Biol. Chem. 282:33776–33787.
Chida, K., Hara, T., Hirai, T., et al. (2003). Disruption of protein kinase Ceta results in impairment of wound healing and enhancement of tumor formation in mouse skin carcinogenesis. Cancer Res. 63:2404–2408.
Chida, K., Sagara, H., Suzuki, Y., et al. (1994). The η isoform of protein kinase C is localized on rough endoplasmic reticulum. Mol. Cell. Biol. 14:3782–3790.
Coghlan, L.G., Gimenez-Conti, I., Kleiner, H.E., et al. (2000a). Development and initial characterization of several new inbred strains of SENCAR mice for studies of multistage skin carcinogenesis. Carcinogenesis 21:641–646.
Coghlan, M.P., Chou, M.M., and Carpenter, C.L. (2000b). Atypical protein kinases Cλ and -ζ associate with the GTP-binding protein Cdc42 and mediate stress fiber loss. Mol. Cell. Biol. 20:2280–2289.
Cohen, E.E.W., Lingen, M.W., Zhu, B., et al. (2006). Protein kinase Cζ mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase. Cancer Res. 66:6296–6303.
Cressman, C.M., Mohan, P.S., Nixon, R.A., et al. (1995). Proteolysis of protein kinase C: mM and μM calcium-requiring calpains have different abilities to generate, and degrade the free catalytic subunit, protein kinase M. FEBS Lett. 367:223–227.
Cross, T., Griffiths, G., Deacon, E., et al. (2000). PKC-delta is an apoptotic lamin kinase. Oncogene 19:2331–2337.
Crotty, T., Cai, J., Sakane, F., et al. (2006). Diacylglycerol kinase δ regulates protein kinase C and epidermal growth factor receptor signaling. Proc. Natl. Acad. Sci. U. S. A. 103:5485–15490.
Czifra, G., Toth, I.B., Marincsak, R., et al. (2006). Insulin-like growth factor-I-coupled mitogenic signaling in primary cultured human skeletal muscle cells and in C2C12 myoblasts. A central role of protein kinase Cδ. Cell Signal 18:1461–1472.
D’Costa, A.M., Robinson, J.K., Maududi, T., et al. (2006). The proapoptotic tumor suppressor protein kinase C-delta is lost in human squamous cell carcinomas. Oncogene 25:378–386.
Datta, R., Kojima, H., Yoshida, K., et al. (1997). Caspase-3-mediated cleavage of protein kinase C theta in induction of apoptosis. J. Biol. Chem. 272:20317–20320.
Dekker, L.V., Palmer, R.H., Parker, P.J. (1995). The protein kinase C and protein kinase C related gene families. Curr. Opin. Struct. Biol. 5:396–402.
Dempsey, E.C., Newton, A.C., Mochly-Rosen, D., et al. (2000). Protein kinase C isozymes and the regulation of diverse responses. Am. J. Physiol. Lung Cell Mol. Physiol. 279:L429–L438.
Denning, M.F. (2004). Epidermal keratinocytes: regulation of multiple cell types by multiple protein kinase isoforms. Int. J. Biochem. Cell Biol. 36:1141–1146.
Denning, M.F., Dlugosz, A.A., Cheng, C., et al. (2000). Cross-talk between epidermal growth factor receptor and protein kinase C during calcium-induced differentiation of keratinocytes. Exp. Dermatol. 9:192–199.
Denning, M.F., Dlugosz, A.A., Howett, M.K., et al. (1993). Expression of an oncogenic ras Ha gene in murine keratinoctyes induces tyrosine phosphorylation and reduced activity of protein kinase C δ. J. Biol. Chem. 268:26079–26081.
Denning, M.F., Dlugosz, A.A., Williams, E.K., et al. (1995a). Specific protein kinase C isozymes mediate the induction of keratinocyte differentiation markers by calcium. Cell Growth Differ. 6:149–157.
Denning, M.F., Kazanietz, M.G., Blumberg, P.M., et al. (1995b). Cholesterol sulfate activates multiple protein kinase C isoenzymes and induces granular cell differentiation in cultured murine keratinocytes. Cell Growth Differ. 6:1619–1626.
Denning, M.F., Wang, Y., Nickoloff, B.J., et al. (1998). Protein kinase C δ is activated by caspase-dependent proteolysis during ultraviolet radiation-induced apoptosis of human keratinoctyes. J. Biol. Chem. 273:29995–30002.
Denning, M.F., Wang, Y., Tibudan, S., et al. (2002). Caspase activation and disruption of mitochondrial membrane potential during UV radiation-induced apoptosis of human keratinocytes requires activation of protein kinase C. Cell Death Differ. 9:40–52.
Deucher, A., Efimova, T., Eckert, R.L. (2002). Calcium-dependent involucrin expression is inversely regulated by protein kinase C (PKC) alpha and PKC delta. J. Biol. Chem. 277:17032–17040.
DeVries, T.A., Neville, M.C., Reyland, M.E. (2002). Nuclear import of PKCdelta is required for apoptosis: identification of a novel nuclear import sequence. EMBO J. 21:6050–6060.
Dietrich, C., Gumpert, N., Heit, I., et al. (2001). Rottlerin induces a transformed phenotype in human keratinocytes. Biochem. Biophys. Res. Commun. 282:575–579.
Dlugosz, A.A., Mischak, H., Mushinski, J.F., et al. (1992). Transcripts encoding protein kinase C-alpha, -delta, -epsilon, -zeta, and -eta are expressed in basal and differentiating mouse keratinocytes in vitro and exhibit quantitative changes in neoplastic cells. Mol. Carcinog. 5:286–292.
Dodd, M.E., Ristich, V.L., Ray, S., et al. (2005). Regulation of protein kinase D during differentiation and proliferation of primary mouse keratinocytes. J. Invest. Dermatol. 125:294–306.
Dries, D.R., Gallegos, L.L., Newton, A.C. (2007). A single residue in the C1 domain sensitizes novel protein kinase C isoforms to cellular diacylglycerol production. J. Biol. Chem. 282:826–830.
Dutil, E.M., Keranen, L.M., DePaoli-Roach, A.A., et al. (1994). In vivo regulation of protein kinase C by trans-phosphorylation followed by autophosphorylation. J. Biol. Chem. 269:29359–29362.
Ebinu, J.O., Bottorf, D.A., Chan, E.Y.W., et al. (1998). RasGRP, a ras guanyl nucleotide-releasing protein with calcium - and diacylglycerol-binding motifs. Science 280:1082–1086.
Eckert, R.L., Sturniolo, M.T., Broome, A.M., et al. (2005). Transglutaminase function in epidermis. J. Invest. Dermatol. 124:481–492.
Efimova, T., Broome, A.M., Eckert, R.L. (2004). Protein kinase Cdelta regulates keratinocyte death and survival by regulating activity and subcellular localization of a p38δ-extracellular signal-regulated kinase 1/2 complex. Mol. Cell. Biol. 24:8167–8183.
Emoto, Y., Manome, Y., Meinhardt, G., et al. (1995). Proteolytic activation of protein kinase Cδ by an ICE-like protease in apoptotic cells. EMBO J. 14:6148–6156.
Fan, J., Guan, S., Cheng, C.F., et al. (2006). PKCδ clustering at the leading edge and mediating growth factor-enhanced, but not ECM-initiated, dermal fibroblast migration. J. Invest. Dermatol. 126:1233–1243.
Farese, R.V., Sajan, M.P., Standaert, M.L. (2005). Insulin-sensitive protein kinases (atypical protein kinase C and protein kinase B/Akt): actions and defects in obesity and type II diabetes. Exp. Biol. Med. 230:593–605.
Farshori, P.Q., Shah, B.H., Arora, K.K., et al. (2003). Activation and nuclear translocation of PKCdelta, Pyk2 and ERK1/2 by gonadotropin releasing hormone in HEK293 cells. J. Steroid Biochem. Mol. Biol. 85:337–347.
Fedorov, Y.V., Jones, N.C., Olwin, B.B. (2002). Atypical protein kinase Cs are the Ras effectors that mediate repression of myogenic satellite cell differentiation. Mol. Cell. Biol. 22:1140–1149.
Fields, A.P., Calcagno, S.R., Krishna, M., et al. (2009). Protein kinase Cβ is an effective target for chemoprevention of colon cancer. Cancer Res.69:1643–1650.
Fima, E., Shtutman, M., Libros, P., et al. (2001). PKCeta enhances cell cycle progression, the expression of G1 cyclins and p21 in MCF-7 cells. Oncogene 20:6794–6804.
Fischer, S.M., Lee, M.L., Maldve, R.E., et al. (1993). Association of protein kinase C activation with induction of ornithine decarboxylase in murine but not human keratinocyte cultures. Mol. Carcinog. 7:228–237.
Fisher, G.J., Tavakkol, A., Leach, K., et al. (1993). Differential expression of protein kinase C isoenzymes in normal and psoriatic adult human skin: reduced expression of protein kinase C-beta II in psoriasis. J. Invest. Dermatol. 101:553–559.
Flescher, E., and Rotem, R. (2002). Protein kinase Cε mediates the induction of P-glycoprotein in LNCaP prostate carcinoma cells. Cell Signal 14:37–43.
Fujiwara, T., Bandi, M., Nitta, M., et al. (2005). Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 437:1043–1047.
Fuchs, E., and Raghavan, S. (2002). Getting under the skin of epidermal morphogenesis. Nat. Rev. Genet. 3:199–209.
Fukunaga, M., Oka, M., Ichihashi, M., et al. (2001). UV-induced tyrosine phosphorylation of PKC delta and promotion of apoptosis in the HaCaT cell line. Biochem. Biophys. Res. Commun. 289:573–579.
Galvez, A.S., Duran, A., Linares, J.F., et al. (2009). Protein kinase Cζ represses the interleukine-6 promoter and impairs tumorigenesis in vivo. Mol. Cell. Biol. 29:104–115.
Gao, T., Brognard, J., Newton, A.C. (2008). The phosphatase PHLPP controls the cellular levels of protein kinase C. J. Biol. Chem. 283:6300–6311.
Gao, T., and Newton, A.C. (2002). The turn motif is a phosphorylation switch that regulates the binding of Hsp70 to protein kinase C. J. Biol. Chem. 277:31585–31592.
Gimond, C., de Melker, A., Aumailley, M., et al. (1995). The cytoplasmic domain of α6A integrin subunit is an in vitro substrate for protein kinase C. Exp. Cell Res. 216:232–235
Giorgione, J.R., Lin, J.H., McCammon, J.A., et al. (2006). Increased membrane affinity of the C1 domain of protein kinase Cδ compensates for the lack of involvement of its C2 domain in membrane recruitment. J. Biol. Chem. 281:1660–1669.
Gokmen-Polar, Y., Murray, N.R., Velasco, M.A., et al. (2001). Elevated protein kinase C βII is an early promotive event in colon carcinogenesis. Cancer Res. 61:1375–1381.
Gonzales-Guerrico, A.M., Meshki, J., Xiao, L., et al. (2005). Molecular mechanisms of protein kinase C-induced apoptosis in prostate cancer cells. J. Biochem. Mol. Biol. 38:639–645.
Gould, C.M., Kannan, N., Taylor, S.S., et al. (2009). The chaperons Hsp90 and Cd37 mediate the maturation and stabilization of protein kinase C through a conserved PXXP motif in the C-terminal tail. J. Biol. Chem. 284:4921–4935.
Gray, M.O., Karliner, J.S., Mochly-Rosen, D. (1997). A selective ε-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J. Biol. Chem. 272:30945–30951.
Griner, E.M., and Kazanietz, M.G. (2007). Protein kinase C and other diacylglycerol effectors in cancer. Nat. Rev. Cancer 7:281–293.
Grossoni, V.C., Falbo, K.B., Mauro, L.V., et al. (2007). Protein kinase Cδ inhibits the production of proteolytic enzymes in murine mammary cells. Clin. Exp. Metastas. 24:513–520.
Gschwendt, M. (1999). Protein kinase C delta. Eur. J. Biochem. 259:555–564.
Gschwendt, M., Kielbassa, K., Kittstein, W., et al. (1994). Tyrosine phosphorylation and stimulation of protein kinase Cd from porcine spleen by src in vitro. Dependence on the activated state of protein kinase Cδ. FEBS Lett. 347:85–89.
Gutschalk, C.M., Herold-Mende, C.C., Fusenig, N.E., et al. (2006). Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth from head and neck squamous cell carcinomas in vivo. Cancer Res. 66:8026–8036.
Hamilton, M., Liao, J., Cathcart, M.K., et al. (2001). Constitutive association of c-N-Ras with c-Raf-1 and protein kinase C epsilon in latent signaling modules. J. Biol. Chem. 276:29079–29090.
Hansen, L.A., Monteiro-Riviere, N.A., Smart, R.C. (1990). Differential down-regulation of epidermal protein kinase C by 12-O-tetradecanoylphorbol-13-acetate and diacylglycerol: association with epidermal hyperplasia and tumor promotion. Cancer Res. 50:5740–5745.
Hansra, G., Garcia-Paramio, P., Prevostel, C., et al. (1999). Multisite dephosphorylation and desensitation of conventional protein kinase C isotypes. Biochem. J. 342:337–344.
Hara, T., Saito, Y., Hirai, T., et al. (2005). Deficiency of protein kinase Cα in mice results in impairment of epidermal hyperplasia and enhancement of tumor formation in two-stage skin carcinogenesis. Cancer Res. 65:7356–7362.
Hecker, E. (1985). Cell membrane associated protein kinase C as receptor of diterpene ester co-carcinogens of the tumor promoter type and the phenotypic expression of tumors. Arzneimittelforschung 35:1890–1903.
Heit, I., Wieser, R.J., Herget, T., Faust, D., et al. (2001). Involvement of protein kinase Cδ in contact-dependent inhibition of growth in human and murine fibroblasts. Oncogene 20:5143–5154.
Helfrich, I., Schmitz, A., Zigrino, P., et al. (2007). Role of aPKC isoforms and their binding partners Par3 and Par6 in epidermal barrier formation. J. Invest. Dermatol. 127:782–791.
Hennings, H., Michael, D., Cheng, C., et al. (1980). Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell 19:245–254.
Hernandez, A.I., Blace, N., Crary, J.F., et al. (2003). Protein kinase Mζ synthesis from a brain mRNA encoding an independent protein kinase Cζ catalytic domain. J. Biol. Chem. 278:40305–40316.
Hirai, T., and Chida, K. (2003). Protein kinase Cζ (PKCζ): activation mechanisms and cellular functions. J. Biochem. 133:1–7.
Horikoshi, Y., Suzuki, A., Yamanaka, T., et al. (2009). Interaction between PAR-3 and the aPKC-PAR-6 complex is indispensable for apical domain development of epithelial cells. J. Cell Sci. 122:1595–1606.
Hornia, A., Lu, Z., Sukezane, T., et al. (1999). Antagonistic effects of protein kinase C alpha and delta on both transformation and phospholipase D activity mediated by the epidermal growth factor receptor. Mol. Cell. Biol. 19:7672–7680.
House, C., and Kemp, B.E. (1987). Protein kinase C contains a pseudosubstrate prototype in its regulatory domain. Science 238:1726–1728.
Huber, M., Siegenthaler, G., Mirancea, N., et al. (2005). Isolation and characterization of human repetin, a member of the fused gene family of the epidermal differentiation complex. J. Invest. Dermatol. 124:998–1007.
Humphries, M.J., Limesand, K.H., Schneider, J.C., et al. (2006). Suppression of apoptosis in the protein kinase Cδ null mouse in vivo. J. Biol. Chem. 281:9728–9737.
Humphries, M.J., Ohm, A.M., Schaack, J., et al. (2008). Tyrosine phosphorylation regulates nuclear translocation of PKCδ. Oncogene 27:3045–3953.
Ikuta, T., Chida, K., Tajima, O., et al. (1994). Cholesterol sulfate, a novel activator for the eta isoform of protein kinase C. Cell Growth Differ. 5:943–947.
Imamoto, A., Wang, X.J., Fujiki, H., et al. (1993). Comparison of 12-O-tetradecanoylphor-bol-13-acetate and teleocidin for induction of epidermal hyperplasia, activation of epidermal PKC isozymes and skin tumor promotion in SENCAR and C57BL/6 mice. Carcinogenesis 14:719–724.
Inoue, M., Kishimoto, A., Takai, Y., et al. (1977). Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. J. Biol. Chem. 252:7610–7616.
Irie, N., Sakai, N., Ueyama, T., et al. (2002). Subtype- and species-specific knockdown of PKC using short interfering RNA. Biochem. Biophys. Res. Commun. 298:738–743.
Ivaska, J., Vuoriluoto, K., Huovinen, T., et al. (2005). PKCε-mediated phosphorylation of vimentin controls integrin recycling and motility. EMBO J. 24:3834–3845.
Izumi, Y., Hirose, T., Tamai, Y., et al. (1998). An atypical PKC directly associates and colocalizes at the epithelial tight junction with ASIP, a mammalian homologue of Caenorhabditis elegans polarity protein PAR-3. J. Cell Biol. 143:95–106.
Jackson, D.N., and Foster, D.A. (2004). The enigmatic protein kinase Cδ: complex roles in cell proliferation and survival. FASEB J. 18:627–636.
Jackson, D., Zheng, Y., Lyo, D., et al. (2005). Suppression of cell migration by protein kinase Cδ. Oncogene 24:3067–3072.
Jaken, S., and Parker, P.J. (2000). Protein kinase C binding partners. Bioessays 22:245–254.
Jansen, A.P., Dreckschmidt, N.E., Verwiebe, E.G., et al. (2001a). Relation of the induction of epidermal ornithine decarboxylase and hyperplasia to the different skin tumor-promotion susceptibilities of protein kinase C alpha, -delta and -epsilon transgenic mice. Int. J. Cancer 93:635–643.
Jansen, A.P., Verwiebe, E.G., Dreckschmidt, N.E., et al. (2001b). Protein kinase C-epsilon transgenic mice: a unique model for metastatic squamous cell carcinoma. Cancer Res. 61:808–812.
Johnson, J.E., Giorgione, J., Newton, A.C. (2000). The C1 and C2 domains of protein kinase C are independent membrane targeting modules, with specificity for phosphatidylserine conferred by the C1 domain. Biochemistry 39:11360–11369.
Joseloff, E., Cataisson, C., Aamodt, H., et al. (2002). Src family kinases phosphorylate protein kinase C delta on tyrosine residues and modify the neoplastic phenotype of skin keratinocytes. J. Biol. Chem. 277:12318–12323.
Joshi, J., Fernandez-Marcos, P.J., Galvez, A., et al. (2008). Par-4 inhibits Akt and suppresses ras-induced lung tumorigenesis. EMBO J. 27:2181–2193.
Kajimoto, T., Shirai, Y., Sakai, N., et al. (2004). Ceramide-induced apoptosis by translocation, phosphorylation, and activation of protein kinase Cδ in the Golgi complex. J. Biol. Chem. 279:12668–12676.
Kanzaki, M., Mora, S., Hwang, J.B., et al. (2004). Atypical protein kinase C (PKCζ/λ) is a convergent downstream target of the insulin-stimulated phosphatidylinositol 3-kinase and TC10 signaling pathways. J. Cell Biol. 164:279–290.
Kashiwagi, M., Ohba, M., Watanabe, H., et al. (2000). PKCeta associates with cyclin E/cdk2/p21 complex, phosphorylates p21 and inhibits cdk2 kinase in keratinocytes. Oncogene 19:6334–6341.
Kasper, M., Regl, G., Frischauf, A.M., et al. (2006). GLI transcription factors: mediators of oncogenic Hedgehog signalling. Eur. J. Cancer 42:437–445.
Kazanietz, M.G., Areces, L.B., Bahador, A., et al. (1993). Characterization of ligand and substrate specificity for the calcium-dependent and calcium-independent PKC isozymes. Mol. Pharmacol. 44:298–307.
Kermorgant, S., Aparicio, T., Dessirier, V., et al. (2001). Hepatocyte growth factor induces colonic cancer cell invasiveness via enhanced motility and protease overproduction. Evidence for PI3 kinase and PKC involvement. Carcinogenesis 22:1035–1042.
Keum, E., Kim, Y., Kwon, S., et al. (2004). Syndecan-4 regulates localization, activity and stability of protein kinase C-α. Biochem. J. 378:1007–1014.
Kiley, S.C., Clark, K.J., Duddy, S.K., et al. (1999a). Increased protein kinase C delta in mammary tumor cells: relationship to transformation and metastatic progression. Oncogene 18:6748–6757.
Kiley, S.C., Clark, K.J., Goodnough, M., et al. (1999b). Protein kinase C δ involvement in mammary tumor metastasis. Cancer Res. 59:3230–3238.
Kishimoto, A., Mikawa, K., Hashimoto, K., et al. (1989). Limited proteolysis of protein kinase C subspecies by calcium-dependent neutral protease (calpain). J. Biol. Chem. 264:4088–4092.
Koizumi, H., Kohno, Y., Osada, S., et al. (1993). Differentiation-associated localization of nPKCη, a Ca++-independent protein kinase C, in normal human skin and skin diseases. J. Invest. Dermatol. 101:858–863.
Konishi, H., Tanaka, M., Takemura, Y., et al. (1997). Activation of protein kinase C by tyrosine phosphorylation in response to H2O2. Proc. Natl. Acad. Sci. U. S. A. 94:11233–11237.
Kuroki, T., Ikuta, T., Kashiwagi, M., et al. (2000). Cholesterol sulfate, an activator of protein kinase C mediating squamous differentiation: a review. Mutation Res. 462:189–195.
Lahn, M., Paterson, B.M., Sundell, K., et al. (2004). The role of protein kinase C-alpha (PKCα) in malignancies of the gastrointestinal tract. Eur. J. Cancer 40:10–20.
Lahn, M., and Sundell, K.L. (2004). The role of protein kinase C-alpha (PKCα) in melanoma. Melanoma Res. 14:85–89.
Langbein, L., Grund, C., Kuhn, C., et al. (2002). Tight junctions and compositionally related junctional structures in mammalian stratified epithelia and cell cultures derived therefrom. Eur. J. Cell Biol. 81:419–435.
Le Good, J.A., and Brindley, D.N. (2004). Molecular mechanisms regulating protein kinase C-zeta turnover and cellular transformation. Biochem. J. 378:83–92.
Le Good, J.A., Ziegler, W.H., Parekh, D.B., et al. (1998). Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281:2042–2045.
Lee, Y.S., Yuspa, S.H., Dlugosz, A.A. (1998). Differentiation of cultured human epidermal keratinocytes at high cell densities is mediated by endogenous activation of the protein kinase C signaling pathway. J. Invest. Dermatol. 111:762–766.
Lehel, C., Olah, Z., Jakab, G., et al. (1995a). Protein kinase Cε is localized to the Golgi via its zinc-finger domain and modulates Golgi function. Proc. Natl. Acad. Sci. U. S. A. 92:1406–1410.
Lehel, C., Olah, Z., Jakab, G., et al. (1995b). Protein kinase C ε subcellular localization domains and proteolytic degradation sites. A model for protein kinase C conformational changes. J. Biol. Chem. 270:19651–19658.
Leinweber, B., Parissenti, A.M., Gallant, C., et al. (2000). Regulation of protein kinase C by the cytoskeletal protein calponin. J. Biol. Chem. 275:40329–40336.
Leitges, M., Sanz, L., Martin, P., et al. (2001). Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway. Mol. Cell 8:771–780.
Leontieva, O.V., and Black, J.D. (2004). Identification of two distinct pathways of protein kinase Cα down-regulation in intestinal epithelial cells. J. Biol. Chem. 279:5788–5801.
Li, L., Lorenzo, P.S., Bogi, K., et al. (1999). Protein kinase Cdelta targets mitochondria, alters mitochondrial membrane potential, and induces apoptosis in normal and neoplastic keratinocytes when overexpressed by an adenoviral vector. Mol. Cell. Biol. 19:8547–8558.
Li, W., Mischak, H., Yu, J.C., et al. (1994a). Tyrosine phosphorylation of protein kinase C-delta in response to its activation. J. Biol. Chem. 269:2349–2352.
Li, W., Yu, J.C., Michieli, P., et al. (1994b). Stimulation of the platelet-derived growth factor β receptor signaling pathway activates protein kinase C-δ. Mol. Cell. Biol. 14:6727–6735.
Li, W., Nadelman, C., Gratch, N.S., et al. (2002). An important role for protein kinase C-delta in human keratinocyte migration on dermal collagen. Exp. Cell Res. 273:219–228.
Li, Y., Wheeler, D.L., Alters, W., et al. (2005). Early epidermal destruction with subsequent epidermal hyperplasia is a unique feature of the papilloma-independent squamous cell carcinoma phenotype in PKCepsilon overexpressing transgenic mice. Toxicol. Pathol. 33:684–694.
Liberman, Z., Plotkin, B., Tennenbaum, T., et al. (2008). Coordinated phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 and protein kinase CβII in the diabetic fat tissue. Am. J. Endocrinol. Metab. 294:E1169–E1177.
Lim, S.T., Longley, R., Couchman, J.R., et al. (2003). Direct binding of syndecan-4 cytoplasmic domain to the catalytic domain of protein kinase Cα (PKCα) increases focal adhesion localization of PKCα*. J. Biol. Chem. 278:13795–13802.
Liu, Y., Su, W., Thompson, E.A., et al. (2004). Protein kinase CβII regulates its own expression in rat intestinal cells and the colonic epithelium in vivo. J. Biol. Chem. 279:45556–45563.
Liu, Y.F., Paz, K., Herschkovitz, A., et al. (2001). Insulin stimulates PKCζ-mediated phosphorylation of insulin receptor substrate-1 (IRS-1). J. Biol. Chem. 276:14459–14465.
Lu, Z., Hornia, A., Jiang, Y.W., et al. (1997). Tumor promotion by depleting cells of protein kinase Cδ. Mol. Cell. Biol. 17:3418–3428.
Lu, Z., Liu, D., Hornia, A., et al. (1998). Activation of protein kinase C triggers its ubiquitination and degradation. Mol. Cell. Biol. 18:839–845.
Luke, C.T., Oki-Idouchi, C.E., Cline, J.M., et al. (2007). RasGRP1 overexpression in the epidermis of transgenic mice contributes to tumor progression during multistage skin carcinogenesis. Cancer Res.67:10190–10197.
Mashukova, A., Oriolo, A.S., Wald, F.A., et al. (2009). Rescue of atypical protein kinase C in epithelia by the cytoskeleton and Hsp70 family chaperones. J. Cell Sci. 122:2491–2503.
Masso-Welch, P.A., Winston, J.S., Edge, S., et al. (2001). Altered expression and localization of PKC eta in human breast tumors. Breast Cancer Res. Treat. 68:211–223.
Masukawa, K., Sakai, N., Ohmori, S., et al. (2006). Spatiotemporal analysis of the molecular interaction between PICK and PKC. Acta Histochem. Cytochem. 39:173–181.
Mellor, H., and Parker, P.J. (1998). The extended protein kinase C superfamily. Biochem. J. 332:281–292.
Michie, A.M., and Nakagawa, R. (2005). The link between PKCα regulation and cellular transformation. Immun. Lett. 96:155–162.
Mills, K.J., Reynolds, S.H., Smart, R.C. (1993). Diacylglycerol is an effector of the clonal expansion of cells containing activated Ha-ras genes. Carcinogenesis 14:2645–2648.
Mills, K.J., and Smart, R.C. (1989). Comparison of epidermal protein kinase C activity, ornithine decarboxylase induction and DNA synthesis stimulated by TPA or dioctanoylglycerol in mouse strains with differing susceptibility to TPA-induced tumor promotion. Carcinogenesis 10:833–838.
Mineo, C., Ying, Y.S., Chapline, C., et al. (1998). Targeting of protein kinase Cα to caveolae.J. Cell Biol. 141:601–610.
Moscat, J., and Diaz-Meco, M.T. (2000). The atypical protein kinase Cs. EMBO Rep. 11:399–403.
Moscat, J., Diaz-Meco, M.T., Rennert, P. (2003). NFκB activation by protein kinase C isoforms and B-cell function. EMBO Rep. 4:31–35.
Moscat, J., Rennert, P., Diaz-Meco, M.T. (2006). PKCζ at the crossroad of NF-κB and Jak/Stat6 signaling pathways. Cell Death Differ. 13:702–711.
Mueller, M.M. (2006). Inflammation in epithelial skin tumours. Eur. J. Cancer 42:735–744.
Murray, N.R., Davidson, L.A., Chapkins, R.S., et al. (1999). Overexpression of protein kinase C betaII induces colonic hyperproliferation and increased sensitivity to colon carcinogenesis. J. Cell Biol. 145:699–711.
Murray, N.R., Weems, J., Braun, U., et al. (2009). Protein kinase C βII and PKCι/λ: collaborating partners in colon cancer promotion and progression. Cancer Res. 69:656–662.
Neill, G.W., Ghali, L.R., Green, J.L., et al. (2003). Loss of protein kinase Cα expression may enhance the tumorigenic potential of Gli1 in basal cell carcinoma. Cancer Res. 63:4692–4697.
Newton, A.C. (1997). Regulation of protein kinase C. Curr. Opin. Cell Biol. 9:161–167.
Newton, A.C. (2003). Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem. J. 370:361–371.
Ng, T., Shima, D., Squire, A., et al. (1999). PKCα regulates β1 integrin-dependent cell motility through association and control of integrin traffic. EMBO J. 18:3909–3923.
Nischt, R., Schmidt, C., Mirancea, N., et al. (2007). Lack of nidogen-1 and -2 prevents basement membrane assembly in skin-organotypic coculture. J. Invest. Dermatol. 127:545–554.
Nishikawa, K., Yamamoto, S., Nagumo, H., et al. (1997). Activation of phorbol ester responsive form of protein kinase C zeta in association with Ca(2+)-induced differentiation of primary cultured mouse epidermal cells. Jpn. J. Pharmacol. 73:171–174.
Nishizuka, Y. (1988). The molecular heterogeneity of PKC and its implications for cellular regulation. Nature 334:661–665.
Nishizuka, Y. (1995). Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 9:484–496.
Novotny-Diermayr, V., Zhang, T., Gu, L., et al. (2002). Protein kinase C delta associates with the interleukin-6 receptor subunit glycoprotein (gp) 130 via Stat3 and enhances Stat3-gp130 interaction. J. Biol. Chem. 277:49134–49142.
Ohba, M., Ishino, K., Kashiwagi, M., et al. (1998). Induction of differentiation in normal human keratinocytes by adenovirus-mediated introduction of the eta and delta isoforms of protein kinase C. Mol. Cell. Biol. 18:5199–5207.
Ohmori, S., Shirai, Y., Sakai, N., et al. (1998). Three distinct mechanisms for translocation and activation of the delta subspecies of protein kinase C. Mol. Cell. Biol. 18:5263–5271.
Oki-Idouchi, C.E., and Lorenzo, P.S. (2007). Transgenic overexpression of RasGRP1 in mouse epidermis results in spontaneous tumors of the skin. Cancer Res. 67:276–280.
Osada, S., Hashimoto, Y., Nomura, S., et al. (1993). Predominant expression of nPKCη, a Ca2+-independent isoform of protein kinase C in epithelial tissues, in association with epithelial differentiation. Cell Growth Differ. 4:167–175.
Osada, S., Mizuno, K., Saido, T.C., et al. (1992). A new member of the protein kinase C family, nPKC theta, predominantly expressed in skeletal muscle. Mol. Cell. Biol. 12:3930–3938.
Oster, H., and Leitges, M. (2006). Protein kinase C α but not PKCζ suppresses intestinal tumor formation in APCMin/+ mice. Cancer Res. 66:6955–6963.
Papp, H., Czifra, G., Bodo, E., et al. (2004). Opposite roles of protein kinase isoforms in proliferation, differentiation, apoptosis, and tumorigenicity of human HaCaT keratinocytes. Cell. Mol. Life Sci. 61:1095–1105.
Paramio, J.M., Segrelles, C., Ruiz, S., et al. (2001). Inhibition of protein kinase B (PKB) and PKCzeta mediates keratin K10-induced cell cycle arrest. Mol. Cell. Biol. 21:7449–7459.
Parekh, D.B., Ziegler, W., Parker, P.J. (2000). Multiple pathways control protein kinase C phosphorylation. EMBO J. 19:496–503.
Parissenti, A.M., Kirwan, A.F., Kim, S.A., et al. (1998). Inhibitory properties of the regulatory domains of human protein kinase Cα and mouse protein kinase Cε. J. Biol. Chem. 273:8940–8945.
Parker, P.J., and Murray-Rust, J. (2004). PKC at a glance. J. Cell Sci. 117:131–132.
Parkinson, S.J., Le Good, J.A., Whelan, R.D.H., et al. (2004). Identification of PKCζII: an endogenous inhibitor of cell polarity. EMBO J. 23:77–88.
Prevostel, C., Alice, V., Joubert, D., et al. (2000). Protein kinase Cα actively downregulates through caveolae-dependent traffic to an endosomal compartment. J. Cell Sci. 113:2575–2584.
Puls, A., Schmidt, S., Grawe, F., et al. (1997). Interaction of protein kinase C ζ with ZIP, a novel protein kinase C-binding protein. Proc. Natl. Acad. Sci. U. S. A. 94:6191–6196.
Pysz, M.A., Leontieva, O.V., Bateman, N.W., et al. (2009). PKCα tumor suppression in the intestine is associated with transcriptional inhibition of cyclin D1. Exp. Cell Res. 315:1415–1428.
Qi, X., and Mochly-Rosen, D. (2008). PKCδ-Abl complex communicates ER stress to the mitochondria - an essential step in subsequent apoptosis. J. Cell Sci. 121:804–813.
Razin, E., Szallasi, Z., Kazanietz, M.G., et al. (1994). Protein kinases C-beta and C-epsilon link the mast cell high-affinity receptor for IgE to the expression of c-fos and c-jun. Proc. Natl. Acad. Sci. U. S. A. 91:7722–7726.
Reddig, P.J., Dreckschmidt, N.E., Ahrens, H., et al. (1999). Transgenic mice overexpressing protein kinase C delta in the epidermis are resistant to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 59:5710–5718.
Reddig, P.J., Dreckschmidt, N.E., Zou, J., et al. (2000). Transgenic mice overexpressing protein kinase C epsilon in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation. Cancer Res. 60:595–602.
Reyland, M.E. (2007). Protein kinase C delta and apoptosis. Biochem. Soc. Transact. 35:1001–1004.
Riobo, N.A., Haines, G.M., Emerson, Jr, C.P. (2006). Protein kinase C-δ and mitogen-activated protein/extracellular signal-regulated kinase-1 control GLI activation in hedgehog signaling. Cancer Res. 66:839–845.
Riobo, N.A., and Manning, D.R. (2007). Pathways of signal transduction employed by vertebrate Hedgehogs. Biochem. J. 403:369–379.
Rosenzweig, T., Braiman, L., Bak, A., et al. (2002). Differential effects of tumor necrosis factor-α on protein kinase C isoforms α and δ mediate inhibition of insulin receptor signaling. Diabetes 51:1921–1930.
Rozengurt, E., Rey, O., Waldron, R.T. (2005). Protein kinase D signaling. J. Biol. Chem. 280:13205–13208.
Rutberg, S.E., Saez, E., Glick, A., et al. (1996). Differentiation of mouse keratinocytes is accompanied by PKC-dependent changes in AP-1 proteins. Oncogene 13:167–176.
Rutberg, S.E., Saez, E., Lo, S., et al. (1997). Opposing activities of c-Fos and Fra-2 on AP-1 regulated transcriptional activity in mouse keratinocytes induced to differentiate by calcium and phorbol esters. Oncogene 15:1337–1346.
Rybin, V.O., Guo, J., Gertsberg, Z., et al. (2008). Phorbol 12-myristate 13-acetate-dependent protein kinase Cδ-Tyr311 phosphorylation in cardiomyocyte caveolae. J. Biol. Chem. 283:17777–17788.
Ryle, C.M., Breitkreutz, D., Stark, H.J., et al. (1989). Density-dependent modulation of synthesis of keratins 1 and 10 in the human keratinocyte line HaCaT and in ras-transfected tumorigenic clones. Differentiation 40:42–54.
Sadagurski, M., Yakar, S., Weingarten, G., et al. (2006). Insulin-like growth factor 1 receptor signaling regulates skin development and inhibits skin keratinocyte differentiation. Mol. Cell. Biol. 26:2675–2687.
Sanchez, P., de Carcer, G., Sandoval, I.V., et al. (1998). Localization of atypical protein kinase C isoforms into lysosome-targeted endosomes through interaction with p62. Mol. Cell. Biol. 18:3069–3080.
Sajan, M.P., Rivas, J., Li, P., et al. (2006). Repletion of atypical protein kinase C following RNA interference-mediated depletion restores insulin-stimulated glucose transport. J. Biol. Chem. 281:17466–17473.
Sakaguchi, M., Miyazaki, M., Sonegawa, H., et al. (2004). PKCalpha mediates TGFbeta-induced growth inhibition of human keratinocytes via phosphorylation of S100C/A11. J. Cell Biol. 164:979–984.
Saurin, A.T., Durgan, J., Cameron, A.J., et al. (2008). The regulated assembly of PKCε complex controls the completion of cytokinesis. Nat. Cell Biol. 10:891–901.
Schechtman, D., and Mochly-Rosen, D. (2001). Adaptor proteins in protein kinase C-mediated signal transduction. Oncogene 20:6339–6347.
Segrelles, C., Moral, M., Lara, M.F., et al. (2006). Molecular determinants of Akt-induced keratinocyte transformation. Oncogene 25:1174–1185.
Selbie, L.A., Schmitz-Peiffer, C., Sheng, Y., et al. (1993). Molecular cloning and characterization of PKC iota, an atypical isoform of protein kinase C derived from insulin-secreting cells.J. Biol. Chem. 268:24296–24302.
Sharkey, N.A., Leach, K.L., Blumberg, P.M. (1984). Competitive inhibition by diacylglycerol of specific phorbol ester binding. Proc. Natl. Acad. Sci. U. S. A. 81:607–610.
Shen, S., Alt, A., Wertheimer, E., et al. (2001). PKCdelta activation: a divergence point in the signaling of insulin and IGF-1-induced proliferation of skin keratinocytes. Diabetes 50:255–264.
Shimao, Y., Nabeshima, K., Inoue, T., et al. (1999). TPA-enhanced motility and invasion in a highly metastatic variant (L-10) of human rectal adenocarcinoma cell line RCM-1: selective role of PKC-alpha and its inhibition by a combination of PDBu-induced PKC downregulation and antisense oligonucleotides treatment. Clin. Exp. Metastas. 17:351–360.
Shtutman, M., Hershko, T., Maissel, A., et al. (2003). PKCeta associates with cyclin E/Cdk2 complex in serum-starved MCF-7 and NIH-3T3 cells. Exp. Cell Res. 286:22–29.
Sitailo, L.A., Tibudan, S.S., Denning, M.F. (2004). Bax activation and induction of apoptosis in human keratinocytes by the protein kinase C δ catalytic domain. J. Invest. Dermatol. 123:434–443.
Sitailo, L.A., Tibudan, S.S., Denning, M.F. (2006). The protein kinase Cδ catalytic fragment targets Mcl-1 for degradation to trigger apoptosis. J. Biol. Chem. 281:29703–29710.
Stanwell, C., Denning, M.F., Rutberg, S.E., et al. (1996). Staurosporine induces a sequential program of mouse keratinocyte terminal differentiation through activation of PKC isozymes. J. Invest. Dermatol. 106:482–489.
Steinberg, S.F. (2004). Distinctive activation mechanisms and functions for protein kinase Cδ. Biochem. J. 384:449–459.
Sumandea, M.P., Rybin, V.O., Hinken, A.C., et al. (2008). Tyrosine phosphorylation modifies protein kinase Cδ-dependent phosphorylation of cardiac troponin I. J. Biol. Chem. 283:22680–22689.
Sun, R., Gao, P., Chen, L., et al. (2005). Protein kinase Cζ is required for epidermal growth factor-induced chemotaxis of human breast cancer cells. Cancer Res. 65:1433–1441.
Suzuki, A., Hirata, M., Kamimura, K., et al. (2004). aPKC acts upstream of PAR-1b in both the establishment and maintenance of mammalian epithelial polarity. Curr. Biol. 14:1425–1435.
Suzuki, A., Ishiyama, C., Hashiba, K., et al. (2002). aPKC kinase activity is required for the asymmetric differentiation of the premature junctional complex during epithelial cell polarization. J. Cell Sci. 115:3565–3573.
Suzuki, A., and Ohno, S. (2006). The PAR-aPKC system: lessons in polarity. J. Cell Sci. 119:979–987.
Suzuki, A., Yamanaka, T., Hirose, T., et al. (2001). Atypical protein kinase C is involved in the evolutionarily conserved PAR protein complex and plays a critical role in establishing epithelia-specific junctional structures. J. Cell Biol. 152:1183–1196.
Svetek, J., Schara, M., Pecar, S., et al. (1995). Spectroscopic characterization of specific phorbol ester binding to PKC-receptor sites in membranes in situ. Carcinogenesis 16:2589–2592.
Szalay, J., Bruno, P., Bhati, R., et al. (2001). Associations of PKC isoforms with the cytoskeleton of B16F10 melanoma cells. J. Histochem. Cytochem. 49:49–65.
Takahashi, H., Asano, K., Manabe, A., et al. (1998). The alpha and eta isoforms of protein kinase C stimulate transcription of human involucrin gene. J. Invest. Dermatol. 110:218–223.
Takai, Y., Kishimoto, A., Iwasa, Y., et al. (1979). Calcium-dependent activation of a multifunctional protein kinase by membrane phospholipids. J. Biol. Chem. 254:3692–3695.
Tan, M., Li, P., Sun, M., et al. (2006). Upregulation and activation of PKCα by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKCα and Src inhibitors. Oncogene 25:3286–3295.
Tapia, J.A., Garcia-Marin, L.J., Jensen, R.T. (2003). Cholecystokinin-stimulated protein kinase C-delta kinase activation, tyrosine phosphorylation, and translocation are mediated by Src tyrosine kinases in pancreatic acinar cells. J. Biol. Chem. 278:35220–35230.
Tennenbaum, T., Weiner, A.K., Belanger, A.J., et al. (1993). The suprabasal expression of α6β4 integrins is associated with a high risk for malignant progression in mouse skin carcinogenesis. Cancer Res. 53:4803–4810.
Tibudan, S.S., Wang, Y., Denning, M.F. (2002). Activation of protein kinase C triggers irreversible cell cycle withdrawal in human keratinocytes. J. Invest. Dermatol. 119:1282–1289.
Tigges, U., Koch, B., Wissing, J., et al. (2003). The F-actin cross-linking and focal adhesion protein filamin A is a ligand and in vivo substrate for protein kinase Cα*. J. Biol. Chem. 278:23561–23569.
Tomakidi, P., Mirancea, N., Fusenig, N.E., et al. (1999). Defects of basement membrane and hemidesmosome structure correlate with malignant phenotype and stromal interactions in HaCaT-ras xenografts. Differentiation 64:263–275.
Tomakidi, P., Stark, H.J., Herold-Mende, C., et al. (2003). Discriminating expression of differentiation markers evolves in transplants of benign and malignant human skin keratinocytes through stromal interactions. J. Pathol. 200:298–307.
Uddin, S., Sassano, A., Deb, D.K., et al. (2002). Protein kinase C-delta (PKCdelta) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727. J. Biol. Chem. 277:14408–14416.
Ueda, E., Ohno, S., Kuroki, T., et al. (1996). The η isoform of protein kinase C mediates transcriptional activation of the human transglutaminase 1 gene. J. Biol. Chem. 271:9790–9794.
Ueffing, M., Lovric, J., Philipp, A., et al. (1997). Protein kinase C-ε associates with the Raf-1 kinase and induces the production of growth factors that stimulate Raf-1 activity. Oncogene 15:2921–2927.
Urtreger, A.J., Grossoni, V.C., Falbo, K.B., et al. (2005). Atypical protein kinase C-ζ modulates clonogenicity, motility, and secretion of proteolytic enzymes in murine mammary cells. Mol. Carcinog. 42:29–39.
Verma, A.K. (1988). Inhibition of tumor promoter 12-O-tetradecanoylphorbol-13-acetate-induced synthesis of epidermal ornithine decarboxylase messenger RNA and diacylglycerol-promoted mouse skin tumor formation by retinoic acid. Cancer Res. 48:2168–2173.
Verma, A.K., Pong, R-C., Erickson, D. (1986). Involvement of protein kinase C activation in ornithine decarboxylase gene expression in primay culture of newborn mouse epidermal cells and in skin tumor promotion by 12-O-teradecanoylphorbol-13-acetate. Cancer Res. 46:6149–6155.
Verma, A.K., Wheeler, D.L., Aziz, M.H., et al. (2006). Protein kinase Cε and development of squamous cell carcinoma, the nonmelanoma human skin cancer. Mol. Carcinog. 45:381–388.
Vetter, M., Blumenthal, S.G., Lindemann, R.K., et al. (2005). Ets1 is an effector of PKCα in cancer cells. Oncogene 24:650–661.
Wang, H.B., Yang, C., Leskow, F.C., et al. (2006). Phospholipase Cγ/diacylglycerol-dependent activation of β2-chimaerin restricts EGF-induced Rac signaling. EMBO J. 25:2062–2074.
Wang, H.Q., and Smart, R.C. (1999). Overexpression of protein kinase C-alpha in the epidermis of transgenic mice results in striking alterations in phorbol ester-induced inflammation and COX-2, MIP-2 and TNF-alpha expression but not tumor promotion. J. Cell Sci. 112:3497–3506.
Wang, Q.J. (2006). PKD at the crossroads of DAG and PKC signaling. Trends Pharmacol. Sci. 27:317–323.
Wang, Q.J., Fang, T.W., Yang, D., et al. (2003). Ligand structure-activity requirements for the binding of phorbol esters to protein kinase D. Mol. Pharmacol. 64:1342–1348.
Wang, Q.J., Lu, G., Schlapkohl, W.A., et al. (2004). The V5 domain of protein kinase C plays a critical role in determining the isoform-specific localization, translocation, and biological function of protein kinase C-δ and -ε. Mol. Cancer Res.2:129–140.
Wang, X.J., Warren, B.S., Beltran, L.M., et al. (1993). Further identification of protein kinase C isozymes in mouse epidermis. J. Cancer Res. Clin. Oncol. 119:279–287.
Wang, Y.C., Hsieh, Y.S., Tang, Y.W., et al. (1999). Protein kinase C isoforms in the epidermal tissues of normal and postburn human skin. Biochem. Mol. Biol. Int. 47:673–679.
Way, K.J., Chou, E., King, G.L. (2000). Identification of PKC-isoform-specific biological actions using pharmacological approaches. Trends Pharmacol. Sci. 21:181–187.
Wheeler, D.L., Li, Y., Verma, A.K. (2005). Protein kinase C epsilon signals ultraviolet light-induced cutaneous damage and development of squamous cell carcinoma possibly through induction of specific cytokines in a paracrine mechanism. Photochem. Photobiol. 81:9–18.
Wheeler, D.L., Reddig, P.J., Dreckschmidt, N.E., et al. (2002). Protein kinase Cδ-mediated signal to ornithin decarboxylase induction is independent of skin tumor suppression. Oncogene 21:3620–3630.
Wilker, E., Lu, J., Rho, O., et al. (2005). Role of PI3K/Akt signaling in insulin-like growth factor-1 (IGF-1) skin tumor promotion. Mol. Carcinog. 44:137–145
Willhauck, M.J., Mirancea, N., Vosseler, S., et al. (2007). Reversion of tumor phenotype in surface transplants of skin SCC cells by scaffold-induced stroma modulation. Carcinogenesis 28:595–610.
Yamanaka, T., Horikoshi, Y., Izumi, N., et al. (2006). Lgl mediates apical domain disassembly by suppressing the PAR-3-aPKC-PAR-6 complex to orient apical membrane polarity. J. Cell Sci. 119:2107–2118.
Yang, C., Liu, Y., Leskow, F.C., et al. (2005). Rac-GAP-dependent inhibition of breast cancer cell proliferation by β2-chimerin. J. Biol. Chem. 280:24363–24370.
Yang, L.C., Ng, D.C., Bikle, D.D. (2003). Role of protein kinase C α in calcium induced differentiation: defective regulation in squamous cell carcinoma. J. Cell Physiol. 195:249–259.
Yuspa, S.H., Kilkenny, A.E., Steinert, P.M., et al. (1989). Expression of murine epidermal differentiation markers is tightly regulated by restricted extracellular calcium concentrations in vitro. J. Cell. Biol. 109:1207–1217.
Zhang, X.A., Bontrager, A.L., Hemler, M.E. (2001). Transmembrane-4-superfamily proteins associate with activated protein kinase C (PKC) and link PKC to specific beta(1) integrins. J. Biol. Chem. 276:25005–25013.
Ziegler, W.H., Tigges, U., Zieseniss, A., et al. (2002). A lipid-regulated docking site on vinculin for protein kinase C. J. Biol. Chem. 277:7396–7404.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Breitkreutz, D., Braiman-Wiksman, L., Daum, N., Tennenbaum, T. (2011). The Protein Kinase C Family: Key Regulators Bridging Signaling Pathways in Skin and Tumor Epithelia. In: Vidal, C. (eds) Post-Translational Modifications in Health and Disease. Protein Reviews, vol 13. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6382-6_8
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6382-6_8
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-6381-9
Online ISBN: 978-1-4419-6382-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)